Navigation Links
GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
Date:11/6/2009

re-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with the HIV virus. A new IND with the FDA is required since this will be the first time the GeoVax vaccine will be used for a therapeutic application. The protocol for the Phase 1 clinical trial, conceived with collaboration from ARCA (AIDS Research Consortium of Atlanta), has specific objectives to optimize safety while evaluating the ability for the vaccine to elicit protective immune responses in vaccinated participants. The proposed trial is based on the achievement of excellent post vaccine viral control in animal trials conducted in recently infected non-human primates at the Yerkes National Primate Research Center, affiliated with Emory University. Assuming a positive outcome from the FDA, the Company expects that the Phase 1 therapeutic trial could begin as early as during the first quarter of 2010. In order to facilitate an understanding of the IND process by GeoVax's shareholders, the Company has prepared a graphical representation of the process, which is available on the Company's website at www.geovax.com.
  • GeoVax's Phase 2a clinical trial for the preventative version of its HIV/AIDS vaccine is ongoing and patient enrollment is proceeding to the Company's satisfaction. This trial, designated as HVTN 205, is being conducted by the HIV Vaccine Trials Network (HVTN). The HVTN, funded and supported by the National Institutes of Allergy and Infectious Disease (NIAID), is the largest worldwide clinical trials network dedicated to the development and testing of HIV/AIDS vaccines. When fully enrolled there will be a total of 225 volunteers (150 vaccine recipients and 75 placebo recipients). The trial is being conducted at 13 HVTN trial sites: 11 in North America and two in South America.
  • On September 24, 200
    '/>"/>

  • SOURCE GeoVax Labs, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
    2. Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine
    3. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
    4. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
    5. GeoVax Reports Progress on Its AIDS Vaccine Technology
    6. GeoVax Secures $10 Million Financing Commitment
    7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
    8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
    9. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
    10. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
    11. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. The delivery of drugs to ... the treatment of neurological disorders. Drugs may be ... (e.g., by intravenous injection) for targeted action in ...
    (Date:6/2/2015)... Canadian Society for Vascular Surgery (CSVS) today released ... that are commonly ordered but not always necessary ... Canada.  The list identifies five (5) targeted, evidence-based ... physicians about what care is really necessary. ... identified the following five (5) recommendations: ...
    (Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Archiving and Communication Systems (PACS) - Global Strategic Business Report" ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... and forecasts are provided for the period 2014 through 2020. ...
    Breaking Medicine Technology:Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
    (Date:6/2/2015)... June 02, 2015 UCLA Health and ... intent to partner and expand urgent care services in ... approval by the University of California Board of Regents ... will allow UCLA Health to purchase a minority share ... Hills, Calabasas, Newbury Park and Northridge and creates opportunity ...
    (Date:6/2/2015)... TMG Health, the leading national provider ... the Medicare Advantage, Medicare Part D, and Managed Medicaid ... at AHIP’s Institute 2015, the annual meeting of the ... will be held June 3-5 in Nashville, Tenn. , ... for attendees to schedule private discussions with senior members ...
    (Date:6/2/2015)... (PRWEB) June 02, 2015 On October ... congressional efforts for another delay. , On Monday, ... Health Subcommittee for the House Ways and Means Committee, ... to Centers for Medicare and Medicaid Services, urging the ... as CMS rolls out ICD-10. ICD-10 is the newest ...
    (Date:6/2/2015)... Angeles, California (PRWEB) June 02, 2015 ... sealers and sorbent systems, has announced the availability ... accidental ingestion of poisons by children, especially curious ... ASTM D3475 standards and tested to CFR 1700.20 ... Director Kevin Cullen. , Looks Like Candy, “With ...
    (Date:6/2/2015)... June 02, 2015 Olive ... opening of Surrey’s first fertility clinic. Surrey ... a diverse, young community, with one of ... , Until now patients from Surrey ... to come into Vancouver or Burnaby for ...
    Breaking Medicine News(10 mins):Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2
    ... women's with damaged or missing wombs by saying in ... to have children normally. // ,After ... transplantation would be possible in humans too without any ... syndrome (a rare congenital condition affecting womb) can also ...
    ... health boards' (DHB) long running disagreement over the funding of ... are forced to travel to Christchurch for specialist treatment. ... the treatment of cervical and other gynecological cancers and was ... has still not been ordered because the DHB wants other ...
    ... plague is a respiratory disease and is endemic to the ... to occur//. If the disease is not diagnosed at an ... If diagnosed at an early stage then the patient can ... disease has already killed 22 people and this highly contagious ...
    ... Institute for Public Health had reported on Thursday that a ... of mad cow disease, last year a woman died from ... Environment (RIVM) did not however disclose any further details about ... issue a statement that eating contaminated meat products would have ...
    ... in Germany have announced progress in their collaborative ... the treatment of hemophilia. ,Extensive in ... synthetic lead molecules with promising pharmacological properties. ... to make important progress in our collaboration with ...
    ... against sunscreen manufacturers in California as they had exaggerated the ... hand still recommend the liberal use of sunscreen. But some ... the label on the products gives a clear picture to ... but do cause aging of the skin and potentially cancer. ...
    Cached Medicine News:Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 2Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 3
    Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
    Coronary angiographic catheter...
    The entirely open modular system is especially suitable for stereotactic microsurgical procedures....
    Used to negotiate tortuous vessels....
    Medicine Products: